The global Animal Parasiticides Market Size was valued at USD 8.61 billion in 2023. The Animal Parasiticides Market industry is anticipated to grow from USD 9.18 billion in 2024 to USD 16.38 billion by 2032, exhibiting a CAGR of 7.51% during the forecast period (2024 - 2032).
Animal parasiticides are chemical formulations used to kill different types of parasites on animals. Animal parasites live on or in the body of animals and can cause irritation, pain, and wounds to animals. Most parasites, if not treated, can cause death of host animal. They can affect the yield of various livestock animals like cattle. The increasing number of livestock animals all over the globe is one of the major factors driving the growth of global animal parasiticides market. Moreover, increasing awareness about animal health management is projected to boost the growth of global animal parasiticides market. Additionally, the increased accessibility to veterinary services due to growth in number of veterinary practitioners coupled with continuous developments in animal parasiticides products is anticipated to fuel the growth of the global animal parasiticides market.
The global animal parasiticides market has been segmented based on product type, livestock, and region.
The global animal parasiticides market has been classified, based on product type, as ectoparasiticides, endoparasiticides, and endectocides.
The global animal parasiticides market has been bifurcated, based on livestock, into ruminants, poultry, porcine, and others.
The global animal parasiticides market has been analyzed for four key regions—North America, Europe, Asia-Pacific, and the rest of the world.
The North American animal parasiticides market has further been segmented into the US, Canada, and Mexico.
The European animal parasiticides market has been classified as the UK, Germany, France, Italy, Spain, and the rest of Europe.
The animal parasiticides market in Asia-Pacific has been divided into China, India, Japan, Australia and New Zealand, and the rest of Asia-Pacific.
The animal parasiticides market, in the rest of the world, has been segmented into South America, the Middle East, and Africa
Vetoquinol, a market leader in animal parasiticides, is pleased to announce that the European Commission has granted marketing authorization for Felpreva® (tigolaner/emodepside/praziquantel), a spot-on prevention and treatment option for mixed parasitic infestations/infections in cats. This authorization was granted subsequent to a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP). Felpreva® is the first spot-on parasiticide designed specifically for cats to provide protection against tapeworms, endoparasites (including gastrointestinal roundworms and lungworms), and ectoparasites (including fleas, lice, and mites) for a duration of up to three months when applied with a single dose. It is authorized for the treatment of felines that are infected with or susceptible to combined parasitic infections. Marketing authorization for Felpreva ® (tigolaner/emodepside/praziquantel) has been issued by the European Commission. For up to three months, the combination product treats both internal and external parasite infestations/infections, including tapeworms, and is the first spot-on solution for cats to receive EU approval. Tigolaner, an innovative active ingredient comprising three components in Felpreva®, primarily targets fleas, ticks, and mites.
Vétoquinol and Bioniche Life Sciences Inc. (Canada), Bayer Animal Health GmbH (Germany), DSM N.V. Merck & Co. Inc. (US), Biomin Holding Gmbh (German), Boehringer Ingelheim International GmbH (Germany), Cargill Inc (US), Zoetis Inc.(US), AB Vista Inc. (UK), The Alltech Groupare (US), Elanco Animal Health Incorporated (US), Bupo Animal Health (South Africa), Chr. Hansen A/S (Denmark), Danisco A/S (Denmark), Novus International Inc. (US) are some of the key players in the global animal parasiticides market.
The market in North-America is expected to dominate the global animal parasiticides market during the forecast period due to increasing demand of food obtained from animal sources, leading to an increase in livestock raising activities. Moreover, the continuous research in animal parasiticides is anticipated to fuel the growth of animal parasiticides market in this region. Asia-Pacific, region is projected to grow at highest CAGR due to increasing awareness about animal health management and its benefits. Additionally, the farmers in developing countries like India and China are now majorly focusing on animal raising activities to obtain more income, which is predicted to boost the growth of global animal parasiticides market.
The animal parasiticides market in the rest of the world is expected to grow at a steady rate due to increasing meat consumption.
October 2023: Bayer Animal Health receives regulatory approval in the European Union (EU) for its new product, NexGard Spectra (afoxolaner/milbemycin oxime). This chewable tablet is indicated for the treatment and prevention of various parasites in dogs and cats, including fleas, ticks, heartworms, and intestinal worms.
November 2023: Elanco Animal Health launches Seresto Plus (imidacloprid/flumethrin/pyriproxyfen), a collar for dogs and cats that provides protection against fleas, ticks, and mosquitoes for up to eight months. This product also helps control flea eggs and larvae in the pet's environment.
July 2023: An advanced parasiticide for companion animals, Simparica Trio® Plus, was launched by Zoetis, which is recognized on the global platform as an expert in animal health care. The formulation consists of three active ingredients that are effective in protecting pets from fleas, ticks, and intestinal worms. The new formulation is designed for ease of use, being more focused on safety, and allowing for easy monthly administration all in one, making it an effective solution for pet owners. During the launch, a digital campaign was run where veterinarians and pet owners were taught the advantages of broad-spectrum parasite prevention. This innovation is further expected to enhance the portfolio of Zoetis and increase its share of the growing companion animal parasiticides market.
May 2023: Adopting a more proactive approach towards protecting pets, Credelio Shield® was launched by Elanco Animal Health in the form of chewable tabs for dogs, which are effective against ticks and heartworm disease. The newly formulated product is not only a seasonal product but can be used throughout the year due to the inclusion of a wider array of active ingredients, making it more effective than its predecessor. Elanco is also working with veterinary clinics around the world to promote the use of Credelio Shield® by increasing awareness of the need to protect pets from parasites. Also, the company has announced its strategies to introduce similar combination products meant for livestock that would be aimed at enhancing productivity while reducing the economic consequences of parasitic infection.
Ectoparasiticides
Endoparasiticides
Endectocides
Ruminants
Poultry
Porcine
Others
North America
US
Canada
Mexico
Europe
Germany
France
Italy
Spain
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Rest of the World (RoW)
South America
Middle East
Africa
Animal growth promoter manufacturers
Livestock industry
Raw material suppliers
Retailers and wholesalers
Traders, importers, and exporters
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)